Overview of HCV and Strategies to Treat HCV Among Patients With Substance Use Disorders Frederick L. Altice, M.D., M.A. Professor of Medicine, Epidemiology and Public Health

First Page		Document Content
Date: 2013-01-14 00:13:23 Viral hepatitis Cirrhosis Hepatitis C Hepatocellular carcinoma Hepatitis Fatty liver Hepato-biliary diseases Hepatitis C and HIV co-infection Medicine Hepatology Health		Overview of HCV and Strategies to Treat HCV Among Patients With Substance Use Disorders Frederick L. Altice, M.D., M.A. Professor of Medicine, Epidemiology and Public Health Add to Reading List Source URL: creidu.edu.au Download Document from Source Website File Size: 3,05 MB Share Document on Facebook

	CLIF Consortium Protocol of the CLIF Acute-oN-ChrONic LIver Failure in Cirrhosis (CANONIC) Core Study Case Report Form DocID: 1v63p - View Document
	Evaluation and Management of the Surgical Patient with Cirrhosis: Understanding and Justifying the Risk Dr. Eternity D. Labio FPCP FPSG FPSDE DocID: 1uVgT - View Document
	INFECTIOUS COMPLICATIONS IN PATIENTS WITH CIRRHOSIS: WHAT SHALL WE DO? Jenny Lim Limquiaco, MD DocID: 1uMjX - View Document
	COMMENTARY High fructose corn syrup (HFCS) plays a dominant role in the pathogenesis of NAFLD-associated cirrhosis Selin Sahin MD, Metin Basaranoglu MD DocID: 1uioY - View Document
	日本消化器病学会肝硬変診療ガイドライン 2015（改訂第 2 版） Evidence-based Clinical Practice Guidelines for Liver Cirrhosis 2015（2nd Edition）日本消化器病学会肝硬変診療ガイド DocID: 1t4b3 - View Document